Global Diclofenac Sodium Market Anticipated to Reach US$ 2,817.3 Million by 2031

According to a recent market study published by Growth Market Reports, titled, “Global Diclofenac Sodium Market by Type, By Disease Indication, By Distribution Channel, and By Region: Size, Share, Trends and Opportunity Analysis, 2016-2031”, the market was valued at US$ 1,861.9 Million in 2022 and is anticipated to expand at a growth rate of 4.9% by 2031.

Diclofenac sodium belongs to a class of medications called non-selective COX inhibitors, which means that it works by inhibiting the enzymes responsible for producing prostaglandins, substances that are involved in pain and inflammation.

Get Sample Report @ https://growthmarketreports.com/request-sample/5883

Diclofenac sodium is available in various forms, including tablets, gels, and injections. It is typically taken orally, although it can be applied topically to the affected area. The medication is absorbed into the bloodstream and distributed throughout the body, where it exerts its anti-inflammatory and analgesic effects. Diclofenac sodium is known for its rapid onset of action, providing relief from pain and inflammation within a short period of time.

The Global Diclofenac Sodium Market has been segmented in terms of type, disease indication, distribution channel, and region. In terms of type, the Global Diclofenac Sodium Market is split into Tablet and Solution. On the basis of disease indication, the market is fragmented into Osteoarthritis, Rheumatoid Arthritis, Migraine, and Others. On the basis of distribution channel, the market is fragmented into Online Pharmacy, Retail Pharmacy, and Hospital Pharmacy. Considering regions, the market is divided into North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa.

The COVID-19 pandemic has affected Diclofenac Sodium market in significant ways. Traditional therapy gained traction in the midst of the pandemic, due to the lack of effective treatments. Inhalation of vapor (VP) is an essential home remedy for a stuffy nose in the common cold, influenza, and sinusitis. Vapor with diclofenac sodium, menthol, methyl salicylate, and N-acetyl cysteine are helpful in this situation. Thus, a trend of using diclofenac sodium during inhalation of vapor supports the diclofenac sodium market. Individuals suffering from COVID-19 prefer using diclofenac sodium as a main ingredient in the vapor, which boosted the market.

Key Takeaways from the Study:

• Players in the Global Diclofenac Sodium Market include Amneal Pharmaceuticals LLC, Aurobindo Pharma Limited, Bayer AG, Cipla Inc, GSK plc., GLENMARK PHARMACEUTICALS LTD, Haleon Group of Companies, krosyl pharmaceutical Pvt. Ltd, Novartis AG, Octavius Pharma Pvt. Ltd, Teva Pharmaceutical Industries Ltd., and Wellona Pharma. Increasing Research and Development is expected to create opportunities in the coming years.

• Based on type, the market is segmented into tablet and solution. The solution segment is expected to hold a considerable share of the market during the forecast period. The tablet segment is registering significant demand during the forecast period, as many individuals prefer oral medications over other forms of medications for pain relief, which is expected to boost the demand for diclofenac sodium tablets.

• Based on the disease indication, the market is segmented into osteoarthritis, rheumatoid arthritis, migraine, and others. The osteoarthritis segment is anticipated to expand at a significant CAGR during the forecast period. The rheumatoid arthritis (RA) segment is anticipated to expand at a significant CAGR during the forecast period, owing to genetic and environmental factors. Exposure to environmental factors, such as smoking and pollutants, triggers RA, as smoking has been implicated as one of the most important extrinsic risk factors for its development and severity. Moreover, the rising prevalence of rheumatoid arthritis drives the market significantly. For instance, as per WHO, in 2019, 18 million people across the world were living with rheumatoid arthritis.

• Based on distribution channel, the market is segmented into online pharmacy, retail pharmacy, and hospital pharmacy. The retail pharmacy segment is expected to hold a considerable share of the market during the forecast period. The hospital pharmacy segment is projected to expand at a considerable CAGR during the forecast period, as hospital pharmacies prepare sterile intravenous medications, ensuring accurate formulations to prevent contamination and maintain patient safety. This feature of hospital pharmacies significantly drives the market.

• Based on regions, the market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.  North America accounted for a significant share of the market in 2022. The market in emerging regions such as Asia Pacific and the Middle East is projected to expand at a significant CAGR during the forecast period, as key players are rapidly increasing their footprints in countries such as India, Japan, the UAE, Saudi Arabia, and others to cater to the demand-supply gap. Investment opportunity in these regions is high, owing to the high requirement for generic diclofenac sodium drug.

Report Scope:

Target Audience:

• Supply-side: Vendor, Manufacturer, Distributors, Supplier, Retailer.

• Regulatory Side: Concerned government authorities, and other approved regulatory bodies.